Sutro Biopharma Stock Performance

Sutro Biopharma Relative Risk vs. Return Landscape

If you would invest  1,100  in Sutro Biopharma on November 1, 2025 and sell it today you would earn a total of  461.00  from holding Sutro Biopharma or generate 41.91% return on investment over 90 days. Sutro Biopharma is currently generating 0.7974% in daily expected returns and assumes 6.6424% risk (volatility on return distribution) over the 90 days horizon. In different words, 59% of stocks are less volatile than Sutro, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Sutro Biopharma is expected to generate 8.91 times more return on investment than the market. However, the company is 8.91 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Sutro Biopharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Sutro Biopharma has a beta of -0.64. This usually implies as returns on the benchmark increase, returns on holding Sutro Biopharma are expected to decrease at a much lower rate. During a bear market, however, Sutro Biopharma is likely to outperform the market. Additionally Sutro Biopharma has an alpha of 0.8244, implying that it can generate a 0.82 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Sutro Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sutro Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 8.97 15.61 22.25 Details

Intrinsic Valuation Low Real High 6.04 12.68 19.32 Details

Naive Forecast Low Next High 10.09 16.73 23.37 Details

10 Analysts Consensus Low Target High 2.44 2.69 2.98 Details

Sutro Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sutro Biopharma is not an exception. The market had few large corrections towards the Sutro Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sutro Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sutro Biopharma within the framework of very fundamental risk indicators.

Sutro Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sutro Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sutro Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Sutro Biopharma Price Density Drivers

Sutro Biopharma Fundamentals Growth

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.

Will Biotechnology sector continue expanding? Could Sutro diversify its offerings? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sutro Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Understanding Sutro Biopharma requires distinguishing between market price and book value, where the latter reflects Sutro's accounting equity. The concept of intrinsic value—what Sutro Biopharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Sutro Biopharma's price substantially above or below its fundamental value.

Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sutro Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.